Literature DB >> 18022480

Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.

Claude Nahmias1, Eric R Carlson, Lisa D Duncan, Todd M Blodgett, Jason Kennedy, Misty J Long, Chris Carr, Karl F Hubner, David W Townsend.   

Abstract

PURPOSE: To investigate the role of 18-fluorine-fluorodeoxyglucose positron emission tomography/computerized tomography ((18)F-FDG PET/CT) in the preoperative prediction of the presence and extent of neck disease in patients with oral/head and neck cancer. PATIENTS AND METHODS: Seventy patients were enrolled in the study, 47 of whom had a clinically negative neck (N0), 19 of whom had a clinically positive unilateral neck (N+), and 4 of whom were negative on 1 side of the neck and positive on the other. Each patient underwent a PET/CT study before undergoing selective neck dissection for N0 disease or modified radical neck dissection for N+ disease. Tissues were submitted for histopathologic examination and were oriented for the pathologist as to the oncologic levels so as to permit correlation between histopathologic findings and the imaging results.
RESULTS: The sensitivity and specificity of the PET/CT procedure were 79% and 82% for the N0 neck, and 95% and 25% for the N+ neck. One hundred ninety-two (11.4%) of the 1,678 nodes identified at histopathology were positive for metastases. The overall nodal sensitivity and specificity were 48% and 99%, respectively.
CONCLUSION: In patients with clinically negative necks, a negative test would not help the surgeon in the management strategy of the patient because of the rate of false-negative results, but a positive test can diagnose metastatic deposits with a high positive predictive value. In patients with clinically positive necks, a positive test will confirm the presence of disease, although false-negative lymph nodes were additionally identified in these clinically positive necks. With respect to nodes, the sensitivity of the imaging procedure is such that the results could not help the surgeon in deciding which level to dissect and which to spare. In the final analysis, the head and neck oncologic surgeon should not depend on the results of the PET/CT scan to determine which patients will benefit from neck dissection. Rather, time-honored principles of neck surgery should be followed, particularly with regard to the liberal execution of prophylactic neck dissections in patients with clinically N0 necks.

Entities:  

Mesh:

Year:  2007        PMID: 18022480     DOI: 10.1016/j.joms.2007.03.010

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  22 in total

1.  The value of PET/CT to assess clinically negative necks.

Authors:  Enver Ozer; Barış Naiboğlu; Ryan Meacham; Cherie Ryoo; Amit Agrawal; David E Schuller
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-15       Impact factor: 2.503

Review 2.  Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.

Authors:  Kazuhiro Kitajima; Yuko Suenaga; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2015-10-27       Impact factor: 2.374

3.  [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.

Authors:  Yuko Suenaga; Kazuhiro Kitajima; Tomonori Kanda; Naoki Otsuki; Ken-Ichi Nibu; Ryohei Sasaki; Tomoo Itoh; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2015-12-15       Impact factor: 2.374

Review 4.  Positron emission tomography for benign and malignant disease.

Authors:  Anthony Visioni; Julian Kim
Journal:  Surg Clin North Am       Date:  2011-02       Impact factor: 2.741

5.  Contrast-enhanced ultrasound mapping of sentinel lymph nodes in oral tongue cancer-a pilot study.

Authors:  Shalva R Gvetadze; Ping Xiong; Mingming Lv; Jun Li; Jingzhou Hu; Konstantin D Ilkaev; Xin Yang; Jian Sun
Journal:  Dentomaxillofac Radiol       Date:  2017-02-17       Impact factor: 2.419

6.  Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.

Authors:  Val J Lowe; Fenghai Duan; Rathan M Subramaniam; JoRean D Sicks; Justin Romanoff; Twyla Bartel; Jian Q Michael Yu; Brian Nussenbaum; Jeremy Richmon; Charles D Arnold; David Cognetti; Brendan C Stack
Journal:  J Clin Oncol       Date:  2019-02-15       Impact factor: 44.544

7.  Predictors and Prevalence of Nodal Disease in Salvage Oropharyngectomy.

Authors:  M E Heft Neal; J Brennan; J C Brenner; A G Shuman; S B Chinn; C L Stucken; K M Malloy; J S Moyer; K A Casper; S A McLean; M E P Prince; C R Bradford; G T Wolf; D B Chepeha; A J Rosko; M E Spector
Journal:  Ann Surg Oncol       Date:  2019-09-19       Impact factor: 5.344

Review 8.  Use of PET in Head and Neck Cancers.

Authors:  Halil Erdem Özel
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-06-01

Review 9.  The diagnosis and treatment of oral cavity cancer.

Authors:  Klaus-Dietrich Wolff; Markus Follmann; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

10.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.